Jacob Appelbaum, MD, PhD

Articles by Jacob Appelbaum, MD, PhD
Is ‘Inflamodulation’ What’s Missing From AML Immunotherapy?
Jerald Radich, MDAcute Myeloid Leukemia | March 11, 2024
This editorial outlines treatments for relapsed AML, T-Cell activation, and more.
Read More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |